News
Johnson & Johnson's stock offers value with promising MedTech growth, raised guidance, strong dividends, and bullish ...
15h
Zacks Investment Research on MSNIs Trending Stock Johnson & Johnson (JNJ) a Buy Now?
Johnson & Johnson (JNJ) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the ...
6d
MarketBeat on MSNJNJ’s Stock Price Is Back in Rally Mode—The Time to Buy Is Now
After years of post-COVID-19 normalization and the impact of its Kenvue spinoff, Johnson & Johnson’s (NYSE: JNJ) stock price ...
1d
Zacks Investment Research on MSNJohnson & Johnson (JNJ) is a Top Dividend Stock Right Now: Should You Buy?
All investors love getting big returns from their portfolio, whether it's through stocks, bonds, ETFs, or other types of securities. However, when you're an income investor, your primary focus is ...
As a baseline, the chance that JNJ will rise over any given week is 54.84%. Therefore, the statistical response to the 6-4-D sequence raises the odds considerably for the bullish speculator.
Johnson & Johnson (NYSE:JNJ) has had a fairly impressive 2016.JNJ began the year like all other stocks by following the market lower. But since its low of $94.28 the stock has been on a tear and ...
Explore more
JNJ's Stock Price & EPS Surprise. J&J has an Earnings ESP of -3.20% and a Zacks Rank #4 (Sell). Per our proven model, companies with the combination of a positive Earnings ESP and a Zacks Rank #1 ...
This 12% rise for JNJ stock since late 2019 can primarily be attributed to 1.Johnson & Johnson’s revenue growth of 16% to $95 billion over the last twelve months, compared to $82 billion in 2019 ...
The Numbers Behind JNJ’s Undervaluation. First, let’s examine JNJ’s valuation to better appreciate the stock. As of August 2024, JNJ is trading at $160.56, with a forward P/E ratio of 20.56 ...
PG stock has witnessed gains of 35% from levels of $125 in early January 2021 to around $170 now, while JNJ stock has shown gains of 15% from levels of $145 to around $165 over this period.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results